TubulisListed
tubulis.combiotech_life_sciences
Tubulis generates uniquely matched antibody-drug conjugates with superior biophysical properties that have demonstrated durable on-tumor delivery and long-lasting anti-tumor activ…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Tubulis generates uniquely matched antibody-drug conjugates with superior biophysical properties that have demonstrated durable on-tumor delivery and long-lasting anti-tumor activ…
ORIC Pharmaceuticals is focused on developing and commercializing innovative therapies that target cancer resistance mechanisms, aiming to enhance the efficacy and longevity of ex…
Circle Pharma is dedicated to transforming cancer treatment through the power of macrocycles, aiming to create effective therapies that minimize side effects for patients.
A2 Biotherapeutics is advancing its Tmod™ cell engineering platform to create precision CAR T-cell therapies, focusing on restoring health and hope for patients with cancer and ot…
AIRNA is committed to delivering the promise of RNA editing to people with rare diseases and common conditions, developing novel medicines with the potential to deliver functional…
Alpha-9 is a leading, clinical stage radiopharmaceutical company, advancing a distinctive portfolio of molecules. Using targeted, bespoke molecules, we treat cancer cells with unp…
Alterome is a clinical-stage biotechnology company focused on developing targeted therapies for cancer, utilizing structure-guided drug discovery and precision oncology.
Alumis is advancing a late-stage portfolio of next-generation targeted therapies for immune-mediated diseases, designed to optimize impact and transform patient care - helping mil…
Ambagon Therapeutics is developing a new class of medicines that can modulate previously undruggable targets and influence currently accessible ones in new ways, focusing on 14-3-…
Ambrx Biopharma Inc is a clinical-stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop next-generation antibody drug conjugat…
Arrakis Therapeutics is pioneering a new class of genetic medicines known as RNA-targeted small molecules (rSMs), aiming to unlock new biology for patients by creating oral medici…
Details are not available yet. The company remains listed.
Arvinas is a biotechnology company focused on developing innovative therapies using its proprietary PROTAC protein degradation platform, aiming to transform drug discovery and imp…
Atavistik Bio is involved in the discovery and development of allosteric therapeutics within the biotechnology sector. The company has a drug discovery platform that identifies an…
Attovia Therapeutics is a clinical-stage biopharmaceutical company focused on immune-mediated diseases, developing next-generation biologic therapies using its proprietary ATTOBOD…
Autolus Therapeutics is a clinical-stage biopharmaceutical company focused on developing next-generation, programmed T cell therapies for the treatment of cancer.
Be Bio is pioneering Engineered B Cell Medicines (BCMs) to dramatically improve the lives of patients who are living with Hemophilia B and other genetic diseases, cancer, and othe…
Black Diamond Therapeutics is a clinical-stage oncology company focused on the development of MasterKey therapies that address families of oncogenic mutations in clinically valida…
Blueprint Medicines is focused on developing innovative therapies for patients with mast cell disorders and solid tumors, utilizing a proven drug discovery platform and robust cli…
Boundless Bio is a clinical stage, next-generation precision oncology company advancing a robust pipeline of the next wave of cancer medicines, ecDNA-directed therapies (ecDTx) fo…
C4 Therapeutics is a biotechnology company focused on developing innovative therapies for cancer treatment using its proprietary technology platform.
CARGO Therapeutics, Inc. is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. CARGO’s programs…
Cleave Biosciences, also known as Cleave Therapeutics, is a biopharmaceutical company focused on protein homeostasis and cellular stress pathways in oncology and neurodegeneration…
Context Therapeutics Inc. is a biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors. The company is focused on developing innovative therapie…
Cullinan Therapeutics focuses on developing targeted therapies for cancer, particularly in immuno-oncology. The company is known for its innovative small molecules and biologics.
Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overac…
EQRx is a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices. The company focuses on high-cost dr…
Exo Therapeutics is focused on unlocking intractable drug targets with exosites, utilizing their ExoSight™ platform to develop innovative therapeutic candidates primarily in oncol…
Hexagon Bio is developing novel ADC payload mechanisms to overcome resistance to today’s payloads and expand the indication space for ADCs, focusing on targeted cytotoxic therapy…
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprieta…
IDEAYA is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapeutics for cancer, particularly through synthetic lethali…
IDRX is a blockchain-based stablecoin pegged 1:1 to the Indonesian Rupiah (IDR). It is designed to provide a stable digital asset for users, minimizing volatility while facilitati…
ITM develops innovative platforms and machines for the production of tobacco heating products and e-vaping solutions, focusing on sustainability and efficiency in manufacturing.
Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to atta…
Translating epigenetic modulation of oncogenic pathways into first-in-class small molecule therapeutics.
Kinnate Biopharma Inc specializes in developing and providing diagnostic devices and tests used for analyzing samples outside the human body to detect diseases and conditions.
Kronos Bio is a clinical-stage biopharmaceutical company developing therapeutics that target the dysregulated transcription that causes cancer and other serious diseases. The comp…
Kura Oncology is focused on the development of precision medicines for the treatment of cancer, utilizing innovative approaches to overcome resistance and identify novel biomarker…
Kymera is a clinical-stage biotechnology company focused on developing innovative medicines through targeted protein degradation, aiming to address critical health problems and im…
Laronde is pioneering a platform that offers a completely novel way of modulating human biology. Endless RNA™ (eRNA), is a uniquely engineered RNA that can be programmed to expres…
Mariana Oncology, a Novartis company, is pioneering novel radioligand therapies designed to optimize cancer treatment efficacy while minimizing side effects for patients.
Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel antibody-drug conjugates (ADCs) for cancer treatment, leveraging proprietary platfor…
Mirati Therapeutics, a clinical-stage oncology company, focuses on the research and development of novel therapeutics targeting the genetic and immunological drivers of cancer. Th…
MOMA Therapeutics is a clinical-stage, next-generation precision medicine company dedicated to targeting highly dynamic proteins that underlie human disease via a small molecule a…
Neon Therapeutics is an immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer. A neoantigen-based product engine allows Ne…
Parabilis is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important target…
Peloton Therapeutics is a biotechnology company focused on developing innovative therapies for cancer treatment through its proprietary drug discovery platform.
PMV Pharmaceuticals is a clinical-stage company focused on the development of precision oncology therapies targeting mutant p53 proteins. Their lead product candidate, rezatapopt,…
ProfoundBio is a company focused on developing innovative antibody-based products to treat cancer and serious diseases.
Relay Therapeutics is a clinical-stage precision medicine company focused on drug discovery through the integration of computational and experimental technologies, particularly ta…
Revolution Medicines is dedicated to discovering, developing, and delivering innovative, targeted medicines for patients living with RAS-addicted cancers. They focus on pioneering…
Sail Biomedicines is a biotech company focused on developing programmable medicines using RNA and nanoparticles, aiming to transform patient care through innovative treatments.
Scorpion is a clinical-stage, precision oncology company developing transformational targeted therapies for patients with cancer. We have built proprietary and fully-integrated di…
Sesame Therapeutics is a healthcare company that provides precision oncology medicines with therapeutic windows.
Silence Therapeutics is a global clinical-stage biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines created…
Silverback Therapeutics is a clinical-stage biopharmaceutical company leveraging their proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted…
Synnovation Therapeutics is a precision medicine company developing small molecule therapies optimized to achieve best-in-class pharmacology against highly validated disease targe…
Tango Therapeutics is leveraging the principle of synthetic lethality to develop genetically targeted therapies for specific tumors, focusing on genetically defined subsets of can…
Details are not available yet. The company remains listed.
Turning Point Therapeutics Inc (TP therapeutics) is a biopharmaceutical company that designs and develops clinical stage small molecule, targeted oncology therapies to address key…
Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. The Com…
Vividion Therapeutics is focused on transforming patient care through small molecule therapeutics, utilizing chemoproteomics and covalent chemistry to target previously undrugged…
Zenith Therapeutics is redefining drug discovery through a new approach to protein degradation, making hard-to-drug targets of high therapeutic value accessible to drug discovery.
Zymeworks is a royalty-driven biotechnology company managing a portfolio of healthcare assets and developing a diverse pipeline of novel, multifunctional biotherapeutics to improv…
Flare Therapeutics is focused on developing small molecule medicines that target transcription factors to treat diseases, particularly in precision oncology. Their pipeline includ…
Discovery and development of therapies to improve the lives of patients with immune-mediated and chronic diseases.